Computational development of rubromycin-based lead compounds for HIV-1 reverse transcriptase inhibition
The binding of several rubromycin-based ligands to HIV1-reverse transcriptase was analyzed using molecular docking and molecular dynamics simulations. MM-PBSA analysis and examination of the trajectories allowed the identification of several promising compounds with predicted high affinity towards r...
Main Authors: | Carlos E.P. Bernardo, Pedro J. Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2014-07-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/470.pdf |
Similar Items
-
Fullerene Derivatives of Nucleoside HIV Reverse Transcriptase Inhibitors—In Silico Activity Prediction
by: Aleksandra Dąbrowska, et al.
Published: (2018-10-01) -
Novel Thiazolidin-4-ones as Potential Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
by: Anthi Petrou, et al.
Published: (2019-10-01) -
HIV-1 protease and reverse transcriptase inhibition by tiger milk mushroom (Lignosus rhinocerus) sclerotium extracts: In vitro and in silico studies
by: Chanin Sillapachaiyaporn, et al.
Published: (2020-07-01) -
Molecular Docking Studies of HIV-1 Resistance to Reverse Transcriptase Inhibitors: Mini-Review
by: Olga Tarasova, et al.
Published: (2018-05-01) -
Computer-Aided Approaches for Targeting HIVgp41
by: William J. Allen, et al.
Published: (2012-08-01)